Precision Survey Institute develops phase-locked vortex matter-wave interferometer
Time of Update: 2023-02-06
Recently, the research team of Jiang Kaijun, Institute of Precision Measurement Science and Technology Innovation, Chinese Academy of Sciences developed a vortex matter wave interferometer based on ultracold atomic gas, and observed the phase locking phenomenon of interference fringes on the two spin components .
Food and Drug Administration: Temporarily extend the time limit for supplementary information for drug registration applications
Time of Update: 2022-10-19
js?cdnversion='+~(-new Date()/36e5)]; In order to thoroughly implement the decision-making and deployment of the Party Central Committee and the State Council on doing a good job in the "six stability" work and implementing the "six guarantees" task, support drug research and development, and promote the development of the pharmaceutical industry, it is decided to temporarily extend the time limit for supplementary information for drug registration applications, which is hereby announced as follows: 1.
Unanimous Konjac IPO: lower issue price after being asked
Time of Update: 2022-09-05
The prospectus shows that from 2019 to 2021, the revenue of Accord Konjac is about 366 million yuan, 379 million yuan and 501 million yuan respectively; the net profit attributable to the parent is about 38.
FSHW tea polyphenols-intestinal microbiota interaction: a multi-element and multi-target approach to improve metabolic syndrome
Time of Update: 2021-10-09
Tea polyphenol – gut microbiota interactions: hints on improving the metabolic syndrome in a multi-element and multi-target manner[J].
Qilu anti-tumor drug first imitation, injection first over-evaluation, 700 million varieties of the third domestic
Time of Update: 2021-01-14
Table 1: Declaration of hydrochloric acid Fashudir injection consistency evaluation supplementary application of the enterprise situation Source: Minet MED2.0 China Drug Review Database At present, in addition to Qilu's first review, the enterprises reporting the hydrochloric acid Fashudir injection consistency evaluation supplementary application also have Yangzijiang, Yuandong, Bert, Red Day and other 5, Abao Pharmaceuticals according to the new classification declaration is also under review and approval.